Grants for Small Businesses

This announcement seeks revolutionary research ideas for topics not being addressed by ongoing BTO programs or other published solicitations. This publication constitutes a Broad Agency Announcement (BAA) as contemplated in Federal Acquisition Regulation (FAR) 6.102(d)(2) and 35.016 and 2 CFR § 200.203. Any resultant award negotiations will follow all pertinent law and regulation, and any negotiations and/or awards for procurement contracts will use procedures under FAR 15.4, Contract Pricing, as specified in the BAA. BTO's mission is to develop capabilities that leverage the unique properties of biology - adaption, replication, resilience and complexity, to revolutionize how the United States defends the homeland and prepares and protects its Warfighters. Research in BTO creates biotechnological capabilities that provide tactical care and restore function to injured warfighters, increase operational resilience, develop novel functional materials, and detect and protect against threats to maintain force readiness.

This funding opportunity provides financial support for research centers focused on improving mental health treatments and services for youth and adults in the U.S. through innovative approaches and collaboration among diverse stakeholders.

This funding opportunity is designed for U.S.-based small businesses to create engaging digital educational tools that teach pre-college students and teachers about biomedical sciences through interactive learning.

This funding opportunity provides financial support for research organizations to establish expert panels that will evaluate and curate genomic variants linked to important diseases, enhancing clinical understanding and treatment options.

This funding opportunity supports early-stage researchers in the U.S. who are pursuing innovative and high-impact projects in infectious, immunologic, and allergic diseases, without requiring extensive preliminary data.

This funding opportunity supports large-scale clinical trials aimed at improving the diagnosis, treatment, and prevention of vision disorders, providing essential resources and services to a wide range of eligible organizations, including universities, nonprofits, and businesses.

This funding opportunity supports organizations conducting large-scale clinical trials focused on innovative treatments for vision disorders, ensuring effective management and oversight of the research process.

This grant provides access to advanced genetic and genomic analysis services for research projects focused on understanding genetic factors in human health and disease, without offering direct funding.

This funding opportunity supports complex clinical trials aimed at improving screening, diagnosis, prevention, or treatment of vision disorders, targeting researchers and institutions capable of leading high-risk studies with significant public health impact.

The National Center for Advancing Translational Sciences (NCATS) intends to publish aNotice of Funding Opportunity (NOFO) to solicit applications for research to advance the diagnosis, management, and treatment of rare diseases. Each Rare Diseases Clinical Research Consortium (RDCRC) will promote highly collaborative, multi-site, patient-centric, translational, and clinical research. It is strongly encouraged that the RDCRC study outcome measures include those that address unmet clinical trial readiness needs that will move the field of research forward from its current state. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in winter 2024, with an expected application due date in summer 2024. This NOFO will utilize the U54 activity code, which supports specialized centers through multi-project cooperative agreement awards to support research activities with substantial involvement from NIH program staff. Details of the planned NOFO are provided below.

This grant provides researchers with access to advanced facilities and technical support for developing non-hormonal contraception and reproductive health products, without direct funding.

This funding opportunity provides financial support to various organizations, including universities and non-profits, to improve veterinary diagnostic capabilities and address public health issues related to animal food safety and antimicrobial resistance.

This funding opportunity supports research projects aimed at reducing stigma related to HIV/AIDS in low- and middle-income countries, with a focus on improving health outcomes for affected populations.

This funding opportunity supports research initiatives focused on non-communicable diseases related to HIV at institutions in low- and middle-income countries, encouraging innovative projects and collaborations to improve health outcomes for people living with HIV.

This funding opportunity supports foundational research in various chemistry subfields for U.S. higher education institutions and nonprofit organizations, promoting advancements in areas like sustainability and advanced manufacturing.

This funding opportunity supports innovative research projects aimed at developing groundbreaking HIV vaccine strategies, encouraging high-risk ideas that diverge from traditional methods and require measurable progress to secure continued funding.

This funding opportunity supports small businesses in developing innovative medical products to help treat and diagnose individuals struggling with opioid and stimulant use disorders.

This funding opportunity supports researchers in developing and validating assays to discover new chemical compounds that could lead to treatments for mental health disorders.

The Rural Business-Cooperative Service is offering a $1.055 billion grant under the Rural Energy for America Program for qualifying renewable energy and energy efficiency projects, with a maximum grant request of $1 million for renewable systems and $500,000 for energy efficiency improvements.

This funding opportunity supports innovative clinical research to explore the brain mechanisms behind substance use disorders, targeting a wide range of researchers and institutions dedicated to addressing addiction challenges.